Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 2, 1996, Pages 309-316

  Bousquet, J ^a   Duchateau, J ^b   Pignat, J C ^c   Fayol, C ^d   Marquis, P ^d   Mariz, S ^e   Ware, J E ^f   Valentin, B ^e   Burtin, B ^e  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c CROIX ROUSSE HOSPITAL   (France)

^d MAPI Institute   (France)

^e UCB PHARMA   (Belgium)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

Cetirizine; Perennial rhinitis; Quality of life; SF 36 questionnaire

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BELGIUM; CETIRIZINE; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; FRANCE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 0029791103     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70155-0     Document Type: Article

References (20)

1. Walker SR, Rosser RM. Quality of Life: assessment and application. Ciba Found Symp 1987:169-78.
2. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med Care1988;26:724-35.
3. Stewart AL, Ware JE, editors. Measuring functioning and well-being. The Medical Outcomes Study approach. Durham, NC: Duke University Press, 1992.
4. McHorney CA. The validity and relative precision of MOS, short- and long-form health status scales and Dartmouth Coop Charts. Med Care 1992;30(5 Suppl):253-65.
5. Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res 1992;1:349-51.
6. Tarlov AP, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989;262:925-30.
7. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes study. JAMA 1989;262:907-13.
8. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.
9. Bousquet J, Knani J, Dhivert H, et al. Quality-of-Life in asthma. I. Reliability and validity of the SF-36 Questionnaire. Am J Respir Crit Care Med 1994;149:371-5.
10. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol 1993;92:66-72.
11. Juniper EF, Guyatt GH, Anderson B, Ferrie PJ. Comparison of power and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy 1993;70:225-30.
12. Rihoux JP, Dupont P. Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl. Ann Allergy 1987;59:235-8.
13. Mansmann HC, Altman RA, Berman BA. Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy 1992;68:348-53.
14. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
15. McHorney CA, Ware JE, Raczeck AE. The MOS-36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
16. Ware JE. SF-36 Health Survey. Manual and interpretation guide. Boston: Nimrod Press, 1993.
17. Biostatistical methodology in clinical trials applications for marketing authorizations for medicinal products. European Community, Note for guidance, III/3630/92 final, 1994.
18. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 Health Survey Questionnaire: new outcome measure for primary care. Br Med J 1992;305:160-4.
19. Jenkinson C, Coulter A, Wright L. The Short Form 36 (SF-36) Health Survey Questionnaire: normative data for adults of working age. Br Med J 1993;306:1437-40.
20. Brooks CD, Karl KJ, Francom SF. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990;20:21-6.